Single-Use Technologies (SUT) in Biosimilar Production
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Single-Use Technologies (SUT) in Biosimilar Production
-
Narrateur(s):
-
Auteur(s):
-
DD ENTERPRISES
À propos de cet audio
Biopharmaceuticals include a wide range of products, such as vaccines, therapeutic proteins, blood
and blood components, and tissues. In contrast to small molecule chemically synthesized drugs, which
have a well-defined structure, biopharmaceuticals derive from living materials (human, animal,
microorganism, or plant) and are much larger and more complex in structure. Because
biopharmaceuticals work with the immune system and do not contain chemical-based drugs, there is
a rapidly expanding acceptance of biopharmaceuticals to treat a range of diseases, and the market is
growing quickly. The biopharmaceutical method of making drugs is an especially high-profile topic due
to the global COVID-19 pandemic and the use of the mRNA vaccine, which is made using the
biopharmaceutical process.
Visit Site>> https://www.ddentp.com/
Copyright 2024 DD ENTERPRISES-
Sep 17 202422 minÉchec de l'ajout au panier.
Veuillez réessayer plus tardÉchec de l'ajout à la liste d'envies.
Veuillez réessayer plus tardÉchec de la suppression de la liste d’envies.
Veuillez réessayer plus tardÉchec du suivi du balado
Ne plus suivre le balado a échoué